// App-Quantinova.ai

11847 2014 AHA : Genotype-Guided Vitamin K Antagonist Dosing Algorithms Improve Time in Therapeutic Range: A Systematic Review and Meta-Analysis

Researchers

Presenter

  • Hasib Hanif

Principal Investigators

  • Frederick -Aragon

  • John Eikelboom

  • Jeffrey L Anderson

  • Mark Borgman

  • Daniel E Jonas

  • Stephen Kimmel

  • Anke H. Maitland-van der Zee

  • Munir Pirmohamed

  • Richard Whitlock

Medical Centers

  • PGXL Labs, Louisville, KY

  • Utrecht University, Utrecht, Netherlands

  • University of Liverpool, Liverpool, United Kingdom

  • McMaster University, Hamilton, ON, Canada

  • Intermountain Medical Ctr, Univ of Utah, Murray, UT

  • University of North Carolina, Chapel Hill, NC

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United States

  • Canada

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Transthyretin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

  • fixed dose

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved